Adult human bone marrow-derived mesenchymal progenitor cells are capable of adhesion-independent survival and expansion

被引:96
作者
Baksh, D
Davies, JE
Zandstra, PW
机构
[1] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada
[2] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada
[3] Univ Toronto, Fac Dent, Toronto, ON M5S 3G9, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
D O I
10.1016/S0301-472X(03)00106-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Overview. We show the existence of adult human mesenchymal progenitor cells (hMPCs) that can proliferate, in a cytokine-dependent manner, as individual cells in stirred suspension cultures (SSC) while maintaining their ability to form functional differentiated mesenchymal cell types. Materials and Methods. Ficolled human bone marrow (BM)-derived cells were grown in SSC (and adherent controls) in the presence and absence of exogenously added cytokines. Phenotypic, gene expression, and functional assays for hematopoietic and nonhematopoietic cell populations were used to kinetically track cell production. Limiting-dilution analysis was used to relate culture-produced cells to input cell populations. Results. Cytokine cocktail influenced total and progenitor cell expansion, as well as the types of cells generated upon plating. Flow cytometric analysis of CD117, CD123, and CD45 expression showed that cytokine supplementation influenced SSC output. The concomitant growth of CD45(+) and CD45- cells in the cultures that exhibited the greatest hMPC expansions suggests that the growth of these cells may benefit from interactions with hematopoietic cells. Functional assays demonstrated that the SSC-derived cells (input CFU-O number: 1990 +/- 377) grown in the presence of SCF + IL-3 resulted, after 21 days, in the generation of a significantly greater number (p < 0.05) of bone progenitors (33,700 +/- 8763 CFU-O) than similarly initiated adherent cultures (214 +/- 75 CFU-O). RT-PCR analysis confirmed that the SSC-derived cells grown in osteogenic conditions express bone-specific genes (Cbfa1/Runx2, bone sialoprotein, and osteocalcin). Conclusions. Our approach not only provides an alternative strategy to expand adult BM-derived nonhematopoietic progenitor cell numbers in a scalable and controllable bioprocess, but also questions established biological paradigms concerning the properties of connective-tissue stem and progenitor cells. (C) 2003 International Society for Experimental Hematology. Published by Elsevier Inc.
引用
收藏
页码:723 / 732
页数:10
相关论文
共 56 条
  • [1] Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34+CD38low/neg human bone marrow cells
    Bennaceur-Griscelli, A
    Tourino, C
    Izac, B
    Vainchenker, W
    Coulombel, L
    [J]. BLOOD, 1999, 94 (02) : 529 - 538
  • [2] BERESFORD JN, 1989, CLIN ORTHOP RELAT R, P270
  • [3] Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
  • [4] Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO
  • [5] 2-F
  • [6] BURROUGHS J, 1994, EXP HEMATOL, V22, P1095
  • [7] Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow
    Campagnoli, C
    Roberts, IAG
    Kumar, S
    Bennett, PR
    Bellantuono, I
    Fisk, NM
    [J]. BLOOD, 2001, 98 (08) : 2396 - 2402
  • [8] Caplan A., 1997, PRINCIPLES TISSUE EN, P603
  • [9] MESENCHYMAL STEM-CELLS
    CAPLAN, AI
    [J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 1991, 9 (05) : 641 - 650
  • [10] Castro-Malaspina H, 1984, Prog Clin Biol Res, V154, P209